Hernán Carranza

902 total citations
36 papers, 417 citations indexed

About

Hernán Carranza is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hernán Carranza has authored 36 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 6 papers in Surgery. Recurrent topics in Hernán Carranza's work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (11 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Hernán Carranza is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (11 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Hernán Carranza collaborates with scholars based in Colombia, Mexico and Spain. Hernán Carranza's co-authors include Andrés F. Cardona, Carlos Vargas, Óscar Arrieta, Jorge Otero, Luis Corrales, Claudio Martín, Alma D. Campos-Parra, Rafael Rosell, Roberto Sánchez-Reyes and July Rodríguez and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hernán Carranza

31 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hernán Carranza Colombia 10 280 245 131 117 28 36 417
Mauricio Cuello Uruguay 8 251 0.9× 189 0.8× 99 0.8× 108 0.9× 26 0.9× 17 330
B. E. Johnson United States 12 388 1.4× 359 1.5× 209 1.6× 101 0.9× 22 0.8× 17 534
Henk Mallo Netherlands 12 183 0.7× 236 1.0× 167 1.3× 65 0.6× 26 0.9× 24 447
Alfonso Illiano Italy 7 299 1.1× 317 1.3× 75 0.6× 108 0.9× 43 1.5× 9 469
Guilherme Harada Brazil 11 161 0.6× 155 0.6× 90 0.7× 66 0.6× 31 1.1× 40 317
Jo Raskin Belgium 10 243 0.9× 178 0.7× 114 0.9× 64 0.5× 34 1.2× 39 392
Alfredo Paredes Spain 7 170 0.6× 192 0.8× 191 1.5× 74 0.6× 35 1.3× 20 344
Swan‐Swan Leong Singapore 6 291 1.0× 246 1.0× 108 0.8× 70 0.6× 62 2.2× 7 461
Emily Feld United States 9 219 0.8× 263 1.1× 164 1.3× 92 0.8× 55 2.0× 17 449
Pauline du Rusquec France 10 160 0.6× 225 0.9× 93 0.7× 66 0.6× 37 1.3× 25 400

Countries citing papers authored by Hernán Carranza

Since Specialization
Citations

This map shows the geographic impact of Hernán Carranza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hernán Carranza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hernán Carranza more than expected).

Fields of papers citing papers by Hernán Carranza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hernán Carranza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hernán Carranza. The network helps show where Hernán Carranza may publish in the future.

Co-authorship network of co-authors of Hernán Carranza

This figure shows the co-authorship network connecting the top 25 collaborators of Hernán Carranza. A scholar is included among the top collaborators of Hernán Carranza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hernán Carranza. Hernán Carranza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barrón, Feliciano, Andrés F. Cardona, Alejandro Ruíz-Patiño, et al.. (2019). PD1.05 Relevance of Antibiotic Use on Clinical Activity of Immune Checkpoint Inhibitors in Hispanic Patients with Advanced Non-small-cell Lung Cancer (CLICAP-ABs). Journal of Thoracic Oncology. 14(11). S1168–S1168. 2 indexed citations
2.
Barrón, Feliciano, Óscar Arrieta, Andrés F. Cardona, et al.. (2019). EP1.04-45 Relevance of Antibiotic Use on Clinical Activity of Immune Checkpoint Inhibitors in Hispanic Patients with Advanced NSCLC (CLICAP-ABs). Journal of Thoracic Oncology. 14(10). S972–S972. 2 indexed citations
3.
Cardona, Andrés F., Leonardo Rojas, Zyanya Lucía Zatarain-Barrón, et al.. (2019). Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP). Frontiers in Oncology. 9. 254–254. 22 indexed citations
4.
Martín, Claudio, Andrés F. Cardona, Zyanya Lucía Zatarain-Barrón, et al.. (2018). Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology Practices. Oncology. 94(5). 297–305. 7 indexed citations
5.
Wills, Beatriz, Andrés F. Cardona, Leonardo Rojas, et al.. (2017). Survival Outcomes According to TIMP1 and EGFR Expression in Heavily Treated Patients with Advanced Non-small Cell Lung Cancer who Received Biweekly Irinotecan Plus Bevacizumab. Anticancer Research. 37(11). 6429–6436. 10 indexed citations
6.
Cardona, Andrés F., Óscar Arrieta, Leonardo Rojas, et al.. (2017). P1.02-050 Acquired Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs) in EGFR-Mutant Lung Adenocarcinoma among Hispanics (Rbiop-CLICaP). Journal of Thoracic Oncology. 12(1). S517–S518. 2 indexed citations
7.
Cardona, Andrés F., Óscar Arrieta, Leonardo Rojas, et al.. (2017). Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP). Targeted Oncology. 12(4). 513–523. 24 indexed citations
8.
Cardona, Andrés F., Óscar Arrieta, Leonardo Rojas, et al.. (2016). O.01: Acquired Resistance to EGFR-TKIs in EGFR-Mutant Lung Adenocarcinoma Among Hispanics (RBIOP-CLICaP). Journal of Thoracic Oncology. 11(10). S168–S168. 1 indexed citations
9.
Rojas, Leonardo, Andrés F. Cardona, Óscar Arrieta, et al.. (2016). PD2.04 (also presented as P1.42): PEM/CBP/BEV Followed by Maintenance PEM/BEV in Hispanic Patients With NSCLC: Outcomes According to TS, ERCC1 and VEGF. Journal of Thoracic Oncology. 11(10). S177–S178. 1 indexed citations
10.
Rojas, Leonardo, Andrés F. Cardona, Óscar Arrieta, et al.. (2016). P1.42 (also presented as PD2.04): PEM/CBP/BEV Followed by Maintenance PEM/BEV in Hispanic Patients With NSCLC: Outcomes According to TS, ERCC1 and VEGF. Journal of Thoracic Oncology. 11(10). S208–S209. 1 indexed citations
11.
12.
Corrales, Luis, Andrés F. Cardona, Óscar Arrieta, et al.. (2016). P2.03: Treatment of Malignant Pleural Mesothelioma Beyond First-Line Among Hispanics (MeSO-CLICaP). Journal of Thoracic Oncology. 11(10). S217–S218. 1 indexed citations
13.
Cardona, Andrés F., Leonardo Rojas, Beatriz Wills, et al.. (2016). Genotyping low-grade gliomas among Hispanics. Neuro-Oncology Practice. 3(3). 164–172. 2 indexed citations
14.
Cardona, Andrés F., Hernán Carranza, Carlos Vargas, et al.. (2016). Epithelial–mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy. Cancer Medicine. 5(8). 1989–1999. 32 indexed citations
15.
Arrieta, Óscar, Andrés F. Cardona, Claudio Martín, et al.. (2015). Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP). Journal of Thoracic Oncology. 10(5). 838–843. 143 indexed citations
16.
Arrieta, Óscar, Andrés F. Cardona, Luis Corrales, et al.. (2014). The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer. Lung Cancer. 87(2). 169–175. 68 indexed citations
17.
Vargas, Carlos, Hernán Carranza, Jorge Otero, & Andrés F. Cardona. (2013). Uso de bevacizumab en pacientes con cáncer de colon metastásico en el Instituto Nacional de Cancerología: una serie de casos. Revista Colombiana de Cancerología. 17(2). 53–54.
18.
19.
Arias, Fernando, Jorge Otero, Andrés F. Cardona, et al.. (2009). Pseudomixoma peritoneal: primeros casos tratados en Colombia con peritonectomía radical y quimioterapia intraperitoneal hipertérmica. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Vargas, Carlos, Andrés F. Cardona, Hernán Carranza, et al.. (2008). Tumores del estroma gastrointestinal (GIST): experiencia en dos instituciones hospitalarias de Bogotá D.C., Colombia (estudio del ONCOLGroup). Redalyc (Universidad Autónoma del Estado de México). 23(3). 213–223. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mauricio Cuello Breakdown of academic impact, for papers by B. E. Johnson Breakdown of academic impact, for papers by Henk Mallo Breakdown of academic impact, for papers by Alfonso Illiano Breakdown of academic impact, for papers by Guilherme Harada Breakdown of academic impact, for papers by Jo Raskin Breakdown of academic impact, for papers by Alfredo Paredes Breakdown of academic impact, for papers by Swan‐Swan Leong Breakdown of academic impact, for papers by Emily Feld Breakdown of academic impact, for papers by Pauline du Rusquec
Rankless by CCL
2026